Loading…
Predictors of Severity of Cerebral Vasospasm caused by Aneurysmal Subarachnoid Hemorrhage
Background Cerebral vasospasm is one of the leading causes of poor outcome after aneurysmal subarachnoid hemorrhage. The risk factors for the development of vasospasm have been evaluated in many clinical studies. However, it remains unclear if vasospasm severity can be predicted. The purpose of this...
Saved in:
Published in: | Journal of stroke and cerebrovascular diseases 2013-11, Vol.22 (8), p.1332-1339 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background Cerebral vasospasm is one of the leading causes of poor outcome after aneurysmal subarachnoid hemorrhage. The risk factors for the development of vasospasm have been evaluated in many clinical studies. However, it remains unclear if vasospasm severity can be predicted. The purpose of this study was to determine if different demographic and clinical factors that appear to be predictors of vasospasm can also prognosticate the severity of cerebral vasospasm. Methods We retrospectively analyzed consecutive patients with subarachnoid hemorrhage who underwent endovascular vasospasm treatment in a single center. In order to define predictors of vasospasm severity, we studied the demographic and clinical characteristics of these patients. Vasospasm severity was defined by cerebral angiography, transcranial Doppler ultrasound, and therapeutic response on endovascular treatment. Statistical analyses were performed to determine significant predictors. Results A total of 70 patients with vasospasm were included. Early onset of mean flow velocities >160 cm/second on transcranial Doppler ultrasound correlated with severity of angiographic vasospasm ( P = .0469) and resistance against intra-arterial papaverine ( P = .0277). Younger age ( |
---|---|
ISSN: | 1052-3057 1532-8511 |
DOI: | 10.1016/j.jstrokecerebrovasdis.2013.01.006 |